Title : Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.

Pub. Date : 2021

PMID : 34347777






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer. Lapatinib ATP binding cassette subfamily B member 1 Homo sapiens
2 Furthermore, we demonstrated direct inhibition of paclitaxel-induced ABCB1 transporter activity by both lapatinib and poziotinib. Lapatinib ATP binding cassette subfamily B member 1 Homo sapiens
3 In conclusion, lapatinib and poziotinib combined with paclitaxel synergizes to inhibit the proliferation of ABCB1-overexpressing ovarian cancer cells in vitro. Lapatinib ATP binding cassette subfamily B member 1 Homo sapiens